"Merck's chief executive says the drugmaker is "raring to go" on deals this year, particularly for small and midsize acquisitions of companies or their experimental drugs. "
Interesting to note that : "Frazier noted Merck did more deals last year than any in recent memory. About half of Merck sales come from drugs initially discovered by researchers elsewhere."
It's nice to be on their radar this year ....
VLA Price at posting:
67.0¢ Sentiment: Buy Disclosure: Held
